News
The U.S. Food and Drug Administration on Thursday expanded the use of Moderna's respiratory syncytial virus vaccine to a ...
KalVista Pharmaceuticals' said on Friday that the U.S. Food and Drug Administration had extended the review of its drug for a ...
Expanded indication builds on existing U.S. FDA approval of mRESVIA for adults aged 60 and older CAMBRIDGE, MA / ACCESS ...
Leaders of the FDA have published a list of new priorities for the agency. They want to deliver rapidly-approved cures and ...
The FDA plans to "unleash AI" on new drug evaluations in order to "radically increase efficiency in the review process." ...
Rein Therapeutics has paused patient enrollment and dosing in a mid-stage trial of its lung disease drug in the U.S. after ...
The U.S. Food and Drug Administration has rolled out a new AI assistant, Elsa, that it says will increase efficiency at its ...
When it comes to the U.S. biopharma market, pricing seems to be the driving focus of most congressional conversations – and ...
US FDA Extends Review of KalVista's Swelling Disorder Drug Due to Heavy Workload By Puyaan Singh (Reuters) -KalVista Pharmaceuticals' said on Friday that the U.S. Food and Drug Administration had ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results